Success Metrics

Active Trials
1(100%)

Phase Distribution

No phase data available

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

1

all time

Status Distribution
Active(1)

Detailed Status

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
1
Active
1
Success Rate
N/A

Trials by Status

recruiting1100%

Recent Activity

1 active trials
Showing 1 of 1
recruiting

A Prospective Cohort Study of Zorifertinib as a First-line Treatment in Patients With Epidermal Growth Factor Receptor-mutant Advanced Non-small Cell Lung Cancer With Central Nervous System (CNS) Metastases

NCT07143045

Clinical Trials (1)

Showing 1 of 1 trials
NCT07143045

A Prospective Cohort Study of Zorifertinib as a First-line Treatment in Patients With Epidermal Growth Factor Receptor-mutant Advanced Non-small Cell Lung Cancer With Central Nervous System (CNS) Metastases

Recruiting

All 1 trials loaded

Drug Details

Intervention Type
Drug
Molecule Type
Small molecule
Total Trials
1

External References

ChEMBL
CHEMBL3623290

Names & Codes

Research Codes

Azd 3759